YES1 and pancreatic neoplasm: YES1 amplification and overexpression are found in a variety of tumors, and siRNA- or shRNA-mediated YES1 downregulation can inhibit the proliferation and growth of rhabdomyosarcoma, NSCLC, and pancreatic cancer cell lines (Garmendia et al., 2022).